Reference : Rimonabant improves cardiometabolic risk factors in overweight/obese patients with po...
Scientific congresses and symposiums : Paper published in a journal
Human health sciences : Endocrinology, metabolism & nutrition
http://hdl.handle.net/2268/7169
Rimonabant improves cardiometabolic risk factors in overweight/obese patients with poorly controlled type 2 diabetes (HbA(1c)>= 8%) on monotherapy with metformin or sulfonylureas
English
Scheen, André mailto [Université de Liège - ULg > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale]
Finer, N. [> > > >]
Jensen, M. [> > > >]
Hollander, P. [> > > >]
Van Gaal, L. [> > > >]
Sep-2006
Diabetologia
Springer
49
Suppl. 1
483-484
Yes (verified by ORBi)
0012-186X
New York
http://hdl.handle.net/2268/7169

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Rimonabant improves cardiometabolic risk factors in.pdfAuthor postprint29.51 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.